{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:31:46Z","timestamp":1777699906320,"version":"3.51.4"},"reference-count":29,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5551\/jat.34884","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T22:07:12Z","timestamp":1464214032000},"page":"39-46","source":"Crossref","is-referenced-by-count":40,"title":["Patients with an Inflamed Atherosclerotic Plaque have Increased Levels of Circulating Inflammatory Markers"],"prefix":"10.5551","volume":"24","author":[{"given":"Pavel","family":"Poredos","sequence":"first","affiliation":[{"name":"Department of Vascular Disease, University Medical Centre Ljubljana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Spirkoska","sequence":"additional","affiliation":[{"name":"Department of Vascular Disease, University Medical Centre Ljubljana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luka","family":"Lezaic","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Medical Centre Ljubljana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojca Bo\u017ei\u010d","family":"Mijovski","sequence":"additional","affiliation":[{"name":"Department of Vascular Disease, University Medical Centre Ljubljana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateja Kaja","family":"Jezovnik","sequence":"additional","affiliation":[{"name":"Department of Vascular Disease, University Medical Centre Ljubljana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Poredo\u0161 P. Peripheral arterial occlusive disease increases the risk of perioperative complications. Vasa. 2014; 43: 401-403","DOI":"10.1024\/0301-1526\/a000386"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108: 1664-1672","DOI":"10.1161\/01.CIR.0000087480.94275.97"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Schwartz SM, Galis ZS, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol. 2007; 27: 705-713","DOI":"10.1161\/01.ATV.0000261709.34878.20"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Rudd JH, Myers KS, Bansilal S, Machac J, Rafique A, Farkouh M. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007; 50: 892-896","DOI":"10.1016\/j.jacc.2007.05.024"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hubalewska-Dydejczyk A, Stomp\u00f3r T, Kalembkiewicz M, Krzanowski M, Mikolajczak R, Sowa-Staszczak A. Identification of inflamed atherosclerotic plaque using 123 I-labeled interleukin-2 scintigraphy in high-risk peritoneal dialysis patients: a pilot study. Perit Dial Int. 2009; 29: 568-574","DOI":"10.1177\/089686080902900516"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: current imaging methods and new perspectives. Stroke. 2005; 36: 2764-2772","DOI":"10.1161\/01.STR.0000190895.51934.43"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford). 1999; 38: 444-447","DOI":"10.1093\/rheumatology\/38.5.444"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006; 48: 1818-1824","DOI":"10.1016\/j.jacc.2006.05.076"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography\/computed tomography (FDGPET\/CT). J Vis Exp. 2012(63): e3777","DOI":"10.3791\/3777"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Jezovnik MK, Zidar N, Lezaic L, Gersak B, Poredos P. Identification of inflamed atherosclerotic lesions in vivo using PET-CT. Inflammation. 2014; 37: 426-434","DOI":"10.1007\/s10753-013-9755-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008; 49: 871-878","DOI":"10.2967\/jnumed.107.050294"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002; 105: 2708-2711","DOI":"10.1161\/01.CIR.0000020548.60110.76"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mallat Z, Taleb S, Ait-Oufella H, Tedgui A. The role of adaptive T cell immunity in atherosclerosis. J Lipid Res. 2009; 50: S364-369","DOI":"10.1194\/jlr.R800092-JLR200"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Libby P. Inflammation in atherosclerosis. Nature. 2002; 420: 868-874","DOI":"10.1038\/nature01323"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sillesen H. What does \u2018best medical therapy' really mean? Eur J Vasc Endovasc Surg. 2008; 35: 139-144","DOI":"10.1016\/j.ejvs.2007.10.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Mallat Z, Corbaz A, Scoazec A, Besnard S, Les\u00e8che G, Chvatchko Y. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 2001; 104: 1598-1603","DOI":"10.1161\/hc3901.096721"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000; 101: 1372-1378","DOI":"10.1161\/01.CIR.101.12.1372"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Schieffer B, Selle T, Hilfiker A, Hilfiker-Kleiner D, Grote K, Tietge UJ. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation. 2004; 110: 3493-3500","DOI":"10.1161\/01.CIR.0000148135.08582.97"},{"key":"19","unstructured":"19) Gr\u00f8nholdt ML, Nordestgaard BG, Bentzon J, Wiebe BM, Zhou J, Falk E. Macrophages are associated with lipidrich carotid artery plaques, echolucency on Bmode imaging, and elevated plasma lipid levels. J Vasc Surg. 2002; 35: 137-145"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Reiker\u00e5s O, Borgen P. Activation of markers of inflammation, coagulation and fibrinolysis in musculoskeletal trauma. PLoS One. 2014; 9: e107881","DOI":"10.1371\/journal.pone.0107881"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Singh SK, Suresh MV, Voleti B, Agrawal A. The connection between Creactive protein and atherosclerosis. Ann Med. 2008; 40: 110-120","DOI":"10.1080\/07853890701749225"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Yamagami H, Kitagawa K, Nagai Y, Hougaku H, Sakaguchi M, Kuwabara K, et al. Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques. Stroke. 2004; 35: 677-681","DOI":"10.1161\/01.STR.0000116876.96334.82"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kleinbongard P, Heusch G, Schulz R. TNFalpha in atherosclerosis, myocardial ischemia\/reperfusion and heart failure. Pharmacol Ther. 2010; 127: 295-314","DOI":"10.1016\/j.pharmthera.2010.05.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000; 101: 2149-2153","DOI":"10.1161\/01.CIR.101.18.2149"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340: 115-126","DOI":"10.1056\/NEJM199901143400207"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res. 2007; 48: 751-762","DOI":"10.1194\/jlr.R600021-JLR200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006; 48: 1825-1831","DOI":"10.1016\/j.jacc.2006.03.069"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Silvola JM, Saraste A, Laitinen I, Savisto N, Laine VJ, Heinonen SE. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques. JACC Cardiovasc Imaging. 2011; 4: 1294-1301","DOI":"10.1016\/j.jcmg.2011.07.009"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Narumi H, Yoshida K, Funabashi N, Hashimoto N, Umehara I, Yoshida S. Abstract 5825: Association between Patterns of FDG Uptake and Arterial Wall Calcification on PET\/CT and Atherogenic Risk Factors in Healthy Subjects. Circulation, 2008: S1012","DOI":"10.1161\/circ.118.suppl_18.S_1012"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/1\/24_34884\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T15:35:32Z","timestamp":1656603332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/1\/24_34884\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.34884","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}